GNAS Complex Locus (GNAS) Peptid
GNAS
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle GNAS Produkte
- GNAS (GNAS Complex Locus (GNAS))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- YFPEFARYTT PEDATPEPGE DPRVTRAKYF IRDEFLRIST ASGDGRHYCY
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GNAS antibody,
Alternative Names: GNAS control peptide, GNAS antibody Blocking Peptide, Anti-GNAS Blocking Peptide, Gnas Complex Locus Blocking Peptide, AHO Blocking Peptide, C20orf45 Blocking Peptide, GNAS1 Blocking Peptide, GNASXL Blocking Peptide, GPSA Blocking Peptide, GSA Blocking Peptide, GSP Blocking Peptide, NESP Blocking Peptide, NESP55 Blocking Peptide, PHP1A Blocking Peptide, PHP1B Blocking Peptide, POH Blocking Peptide, XL2 Blocking Peptide, XLalphas Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- GNAS (GNAS Complex Locus (GNAS))
- Hintergrund
- This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors.
- Molekulargewicht
- 42 kDa
-
Sie sind hier:
